FDA Grants Orphan Drug Designation to MicuRx’s MRX-5 for NTM Infections
SHANGHAI, Jan. 1, 2025 /PRNewswire/ — Shanghai MicuRx Pharmaceutical Co., Ltd. (“MicuRx”，688373.SH) announced that MRX-5, its self-developed... Read more.
OrangeX Aligns with Upcoming MiCAR Regulations through Proactive Compliance Strategies
VICTORIA, Seychelles, Jan. 1, 2025 /PRNewswire/ — December 30, 2024, just marked a pivotal moment for the cryptocurrency industry as the European Union Markets... Read more.
KuCoin Advances the “Menstrual Equity Project”, Benefiting 4,000 Women in the Bahamas
NASSAU, Bahamas, Jan. 1, 2025 /PRNewswire/ — On December 31, 2024, the “Menstrual Equity Project” , jointly initiated by KuCoin, Global CSR Foundation,... Read more.
SMART 2025: Shaping the Future of Wellness During CES Week
LAS VEGAS, Jan. 1, 2025 /PRNewswire/ — AI Wellness proudly launches the SMART 2025 Initiative during CES Week, setting the stage for a transformative year... Read more.
VAPORESSO Strengthens Global Efforts to Combat Counterfeit
SHENZHEN, China, Jan. 1, 2025 /PRNewswire/ — Recently, reports of counterfeit products and substandard compatible pods entering the market have disrupted sales... Read more.
Leading the Way: LiuGong’s Global Sustainability Milestones in 2024 and Beyond
LIUZHOU, China, Jan. 1, 2025 /PRNewswire/ — From pioneering practices to impactful collaborations, LiuGong (000528.SZ) has consistently demonstrated its dedication... Read more.
Green Tech Accelerator: Empowering Taiwanese SMEs Toward Net-Zero Emissions and Building a Global Green Tech Ecosystem
TAIPEI, Jan. 1, 2025 /PRNewswire/ — A news report from Business Next Media Group: Green Tech Accelerator aims to bridge the carbon reduction knowledge gap... Read more.
MICROIP Debuts at CES 2025, Showcasing Rapid ASIC Design and AI Innovation
TAIPEI, Jan. 1, 2025 /PRNewswire/ — MICROIP is redefining IC design by integrating AI software services and pioneering a “Designless” approach,... Read more.
Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate
SAN FRANCISCO and SUZHOU, China, Jan. 1, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical... Read more.
Best Companies for Introverts 2025
On World Introvert Day, HushLoudly recognizes companies demonstrating a commitment to introvert inclusion CHICAGO, Jan. 1, 2025 /PRNewswire/ — HushLoudly,... Read more.